1.Characteristics of interleukin 4-induced CD23 positive human B cells.
Korean Journal of Immunology 1992;14(1):9-14
No abstract available.
B-Lymphocytes*
;
Humans*
;
Interleukins*
2.Characteristics of interleukin 4-induced CD23 positive human B cells.
Korean Journal of Immunology 1992;14(1):9-14
No abstract available.
B-Lymphocytes*
;
Humans*
;
Interleukins*
3.Mycological and Clinical Study on Dermatophytoses in Infants and Preschoolers.
Eun Hee CHOO ; Guk Joo CHOI ; Baik Kee CHO
Korean Journal of Dermatology 1984;22(4):369-374
The clinical and mycological study was made with 38 cases of dermatophytoses in infants and preschoolers in dermatologic clinic of St. Pauls Hospital, Catholic Medical College, from September, 1982 to April, 1984. Following results are obtained: The incidence of dermatophytoses under the age 6 was 2. 2% among 1, 711 out- patients of the sarne age group. 2. The incidence of involving sites was the highest in tinea(T.) corporis(37. 2%) and T. faciale(37, 2%) and then T. capitis(18. 7g). In 0-under 2 groups, the highest incidence in T. corporis(54. 5%) and then T. faciale(3l. 8%.). In 4-under 5 group, the highest incidence in T. capitis(55. 6%). 3 Fungi cultured from their skin lesions were 36 strains belonging to 6 species. These were M. canis(55. 6%), T. rabrum(27. 8%), granular type of T.mentagrophyte(8.3%) and interdigital type of T. mentagrophyte(27. 8%), M gypseum (2.8%). and E. floccosum(2.8%) in order. 4. Arnong 1Q strains of T. rabrum, anthropophilic fungi, 8 strains(80. 0%) were frorn 0-under 2 age groups, E. floccosum, and interdigital type of T. mentagrophyte were also from 0-under 1 age group. Among ZO strains of M, canis, zoophilic fungi, 13 strains(65. 0%) were from the age groups of 2-under 5. Granular type of T. mentagrophytc, 2 among 3 strains were from 4-under 5 age group, 5. The incidence of causative fungi in each sites were as follows: In T. corporis, T. rubrum(50. O%), and M canis(18. 8%) in order. In T. faciale, M. canis(62. 5%), T. rabrum(12. 5%), T. mentagrophyte(12. 5%), and M. gypseum(6. 3%) in order. In T. capitis, all cultured fungi were M. canis
Fungi
;
Humans
;
Incidence
;
Infant*
;
Skin
;
Tinea*
4.Overview of Roles for Non-cardiac Natriuretic Peptides: Roles in Neural, Endocrine and Immune Systmes.
Kyung Woo CHO ; Suhn Hee KIM ; Sung Joo KIM
Journal of Korean Society of Endocrinology 2000;15(6):760-778
No Abstract Available.
Natriuretic Peptides*
5.The effects of differentiation and glucocorticoid treatment on the expression of lipocortin 1 in U937 cells.
Young Joo CHO ; Hee Bom MOON ; Do Sun NA
Korean Journal of Allergy 1997;17(2):119-128
Lipocortin represents a family of similar Ca++ depentent phospholipid-binding proteins capable of blocking the activity of phospholipase A2 (PLA2) in vitro. Generally, these proteins are believed to inhibit the release of arachidonic acid from photopholipids and the formation of lipid mediators such as prostaglandin, leukotriene, and platelet activating factor. Lipocortin 1, initially identified as a glucocorticoid- responsive protein in macrophages and neutrophils has been implicated in transmembrane signal transduction during growth factor-mediated cell proliferation and transformation. To define the synthesis and its regulation, we investigated the expression of lipocortin 1 in both the mRNA and protein level in U937 cell line in the presence of several differentiation factors. The results were as follows. 1. The expression of lipocortin 1 and its mRNA was increased during TPA-induced differentiation of U937 cells to maximum of 2-fold and 5-fold respectively. Both the protein and mRNA levels decreased after 48 hours. 2. With the treatment with IFN-gamma, the expression of CD16 was increased. However, the protein and mRNA levels of lipocortin 1 were, not changed significantly. 3. Neither the dexamethasone or hydrocortisone have any effects on the expression of lipocortin 1 in both TPA-differentiated and undifferentiated U937 cells. The results from this study would give a light on defining the functional role of lipocortin 1 in macro-moncycle cell lineage and possibly some informative clues for the pathogenic mechanisms of the inflammatory diseases.
Annexin A1*
;
Annexins*
;
Arachidonic Acid
;
Cell Lineage
;
Cell Proliferation
;
Dexamethasone
;
Humans
;
Hydrocortisone
;
Macrophages
;
Neutrophils
;
Phospholipases A2
;
Platelet Activating Factor
;
RNA, Messenger
;
Signal Transduction
;
U937 Cells*
6.Immediate early genes and preproenkephalin gene expression in the rat nucleus caudalis after trigeminal stimulation.
Hee Jung CHO ; Ho Sup LEE ; Kang JOO
Korean Journal of Anatomy 1993;26(4):352-360
No abstract available.
Animals
;
Gene Expression*
;
Genes, Immediate-Early*
;
Rats*
7.Extended Approach of EMR (ESD) in Stomach Cancer: Pro.
Joo Young CHO ; Weon Young CHO ; Tae Hee LEE
Journal of the Korean Gastric Cancer Association 2008;8(1):1-4
No abstract available.
Stomach
8.Relationships between osteoporosis and pathologic fractures.
Sung Joon KIM ; Jae Lim CHO ; Joo Hee HAN ; Suk Shin CHO
The Journal of the Korean Orthopaedic Association 1992;27(5):1284-1292
No abstract available.
Fractures, Spontaneous*
;
Osteoporosis*
9.Transabdominal Selective Fetal Reduction in Multifetal Pregnancy.
Jeong Joo MOON ; Nam Hee LEE ; Mi Eun JEONG ; Ji Yeong CHO ; Chung Hee CHUN
Korean Journal of Obstetrics and Gynecology 1997;40(8):1594-1601
Over the past 30 years, there has been an increase in the incidence of multifetal pregna-ncies, primarily because of the introduction of ovarian stimulants for ovulation induction and assisted reproductive technology ( ART ) in infertile patients. It is well established that multifetal pregnancies are associated with an increased frequency of the maternal complications and gre-ater perinatal morbidity and mortyality. The adverse outcome of multifetal pregnancies is dire-ctly proportional to the number of fetuses, primarily as an consequence of prterm delivery. Re-duction in the number of fetuses in multifetal pregnancies has been proposed as a way to impr-ove the perinatal outcome in this situation. Therefore, selective fetal reduction ( SFR ) is sugges-ted as a therapeutic option for continuation of pregnancy with fetuses mature enough to survi-ve. In this paper, we report our infertility clinic experiences with 6 patients who carried mult- ifetal pregnancies including 1 quintuplet, 1 quadruplet, and 4 triplets. from January, 1991 to May, 1996, transabdominal SFR was accomplished by fetal intrathoracic KCl injection at 9~10 weeks of gestation. After the prcedure, 4 patients remained as twin pregnancies, and 2 patients as single pregnancy. There have been 3 sets of twin deliveries and the 2 sets of single delivery. One case was aborted. Two patients were delivered after 37 weeks of gestation, 2 patients were at 35 weeks, and 1 patient at 24 weeks. All babies have been healthy after birth in patients after 35 weeks gestation. There was no fetal anomaly related to the procedure in the 6 cases. We concluded that transabdominal SFR is a rather safe and useful procedure that may improve the outcome of multifetal pregnancies.
Fetus
;
Humans
;
Incidence
;
Infertility
;
Ovulation Induction
;
Parturition
;
Pregnancy Reduction, Multifetal*
;
Pregnancy*
;
Pregnancy, Twin
;
Quadruplets
;
Quintuplets
;
Reproductive Techniques, Assisted
;
Triplets
;
Twins
10.Malignant Acanthosis Nigricans Associated with Stomach Adenocarcinoma.
Young Hee JEE ; Eun Joo SEO ; Mi Kyung HUR ; Chin Hee CHO ; Sun Moo KIM
Korean Journal of Pathology 1985;19(1):88-91
Malignant acanthosis nigricans is very rare disease. The disease is related with internal malignancy, especially gastrointestinal tract malignancy. Reported occurrence rate of malignant acanthosis nigricans associated internal malignancies are 64% of stomach adenocarcinoma, 27% of other organs of abdomen (liver, gall bladder, small intestine, rectum, uterus, ovary), 9% of non-abdominal organs(breast, lung). We report a case of malignant acanthosis nigricans associated with stomach adenocarcinoma from 20-year-old female and discuss review of literature on a acanthosis nigricans briefly.
Female
;
Humans
;
Adenocarcinoma